News

MANILA, Philippines — Senate President Francis `Chiz' Escudero has moved the presentation of the articles of impeachment against Vice President Sara Duterte from June 2 to June 11. In a ...
Check out exclusive photos of your favorite stars — including Hayden Christensen, Ayo Edebiri, Martin Short, and more — posing backstage at the Disney 2025 upfront presentation.
MediWound publishes analysis showing EscharEx® outperforms SANTYL® in treating venous leg ulcers, highlighting faster debridement and wound healing.
Compared to SANTYL, ... The article, titled “Bromelain-Based Debridement Versus Collagenase Ointment Debridement of Venous Leg Ulcers: Post Hoc Analysis of the ChronEx Trial, ...
Post hoc analysis published in the peer-reviewed journal Wounds highlights EscharEx®’s superior clinical performance and comparable safety profile to SANTYL®YAVNE, Israel, May 13, 2025 (GLOBE ...
Post hoc analysis published in the peer-reviewed journal Wounds highlights EscharEx®’s superior clinical performance and comparable safety profile to SANTYL®YAVNE, Israel, May 13, 2025 (GLOBE NEWSWIRE ...
The article , titled“Bromelain-Based Debridement Versus Collagenase Ointment Debridement of Venous Leg Ulcers: Post Hoc Analysis of the ChronEx Trial,” appears in the April 2025 edition of ...
The article, titled "Bromelain-Based Debridement Versus Collagenase Ointment Debridement of Venous Leg Ulcers: Post Hoc Analysis of the ChronEx Trial,” appears in the April 2025 edition of Wounds ...
Micron stock slid Friday following the company's fiscal second-quarter results. Several analysts maintained bullish ratings, however, based in part on an improving outlook for its DRAM chips.
Santyl Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 The Business Research Company's Santyl Global Market Report 2025 – Tuesday, 02 January 2024 12:17 GMT.
YAVNE, Israel, Oct. 10, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will be ...